A NIR-II AIE luminogen based nanoplatform with nitric oxide controlled release properties for NIR-II fluorescence guided combined photodynamic/photothermal/gas therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. A near-infrared triggered multi-functional indocyanine green nanocomposite with NO gas release function inducing improved photothermal therapy10.1016/j.jcis.2024.10.071 ↗
2. Cationic conjugated polymer coupled non-conjugated segments for dually enhanced NIR-II fluorescence and lower-temperature photothermal-gas therapy10.1186/s12951-024-02741-9 ↗
3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
5. Cancer treatment therapies: traditional to modern approaches to combat cancers10.1007/s11033-023-08809-3 ↗
6. Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide combined cancer therapy10.1016/j.cej.2024.148618 ↗
7. Near-infrared-triggered Dibenzo[a,c][1,2,5]thiadiazolo[3,4-i]phenazine heterocyclic derivatives for type-I photodynamic and photothermal therapy against human nasopharyngeal carcinoma10.1016/j.dyepig.2024.112133 ↗
8. Nanostructured cruciform phototheranostic agents for efficient multimodal imaging-guided type I photodynamic/photothermal synergistic therapy10.1016/j.dyepig.2024.112283 ↗
9. Optimizing phototherapy efficiency via dynamic adjusting the contributions of photodynamic and photothermal therapy of diketopyrrolopyrrole-based compounds10.1016/j.dyepig.2024.112049 ↗
10. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
11. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation10.1038/s41467-023-38601-7 ↗
12. Advent in proteins, nucleic acids, and biological cell membranes functionalized nanocarriers to accomplish active or homologous tumor targeting for smart amalgamated chemotherapy/photo-therapy: a review
13. Light-triggered nitric oxide nanogenerator with high L-arginine loading for synergistic photodynamic/gas/photothermal therapy10.1002/adhm.202300012 ↗
14. An asymmetric NIR-II organic fluorophore with an ultra-large stokes shift for imaging-guided and targeted phototherapy10.1021/acsbiomaterials.4c00496 ↗
15. Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging10.1002/adma.202305668 ↗
16. Molecular engineering of NIR‐II/IIb emitting AIEgen for multimodal imaging-guided photo-immunotherapy10.1002/smll.202300859 ↗
17. Near-infrared II fluorescence imaging10.1038/s43586-024-00301-x ↗
18. Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: from near-infrared-I to near-infrared-II10.1016/j.jconrel.2023.08.056 ↗
19. NIR-II aggregation-induced emission luminogens for tumor phototheranostics10.3390/bios12010046 ↗
20. Regulating aggregation-induced emission luminogen for multimodal imaging-navigated synergistic therapy involving anti-angiogenesis10.1002/advs.202302713 ↗
21. BODIPY-based nanoparticles for highly efficient photothermal/gas synergistic therapy against drug-resistant bacterial infection10.1007/s10853-024-10351-x ↗
22. Gas therapy: generating, delivery, and biomedical applications10.1002/smtd.202301349 ↗
23. Photothermal/NO combination therapy from plasmonic hybrid nanotherapeutics against breast cancer10.1016/j.jconrel.2022.03.030 ↗
24. Recent advances on the development of NO-releasing molecules (NORMs) for biomedical applications10.1016/j.ejmech.2024.116217 ↗
25. Opportunities for nitric oxide in potentiating cancer immunotherapy10.1124/pharmrev.121.000500 ↗
26. The triple crown: NO, CO, and H2S in cancer cell biology10.1016/j.pharmthera.2023.108502 ↗
27. Nitric oxide: physiological functions, delivery, and biomedical applications10.1002/advs.202303259 ↗
28. Current advances of nitric oxide in cancer and anticancer therapeutics10.3390/vaccines9020094 ↗
29. Insights on the functional dualism of nitric oxide in the hallmarks of cancer10.1016/j.bbcan.2023.189001 ↗
30. Doxorubicin hydrochloride and L-arginine co-loaded nanovesicle for drug resistance reversal stimulated by near-infrared light
31. Emerging nitric oxide gas-assisted cancer photothermal treatment
32. Nitric oxide-photodelivering materials with multiple functionalities: from rational design to therapeutic applications10.1021/acsami.4c13478 ↗
33. Customized A-D-A type molecule to construct a nitric oxide nanogenerator with enhanced antibacterial activity for infected wound healing10.1039/D4TB01201A ↗
34. NIR-II AIEgens: a win-win integration towards bioapplications10.1002/anie.202005899 ↗
35. Precise molecular design for high-performance luminogens with aggregation-induced emission10.1002/adma.201903530 ↗
36. Biologically excretable aggregation-induced emission dots for visualizing through the marmosets intravitally: horizons in future clinical nanomedicine10.1002/adma.202008123 ↗
37. BF2-bridged azafulvene dimer-based 1064 nm laser-driven superior photothermal agent for deep-seated tumor therapy10.1002/anie.202407307 ↗
38. Promoted NIR-II fluorescence by heteroatom-inserted rigid-planar cores for monitoring cell therapy of acute lung injury
39. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
40. Near-infrared II agent with excellent overall performance for imaging-guided photothermal thrombolysis10.1021/acsnano.4c06965 ↗
41. An active self-mitochondria-targeting cyanine immunomodulator for near-infrared II fluorescence imaging-guided synergistic photodynamic immunotherapy10.1002/adhm.202401061 ↗
42. Integration of motion and stillness: a paradigm shift in constructing nearly planar NIR-II AIEgen with ultrahigh molar absorptivity and photothermal effect for multimodal phototheranostics10.1021/jacs.4c15216 ↗
43. Toward type I/II ROS generation photoimmunotherapy by molecular engineering of semiconducting perylene diimide10.1002/adhm.202303175 ↗
44. BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy10.1016/j.bios.2023.115895 ↗
45. Photo‐triggered cascade therapy: a NIR-II AIE luminogen collaborating with nitric oxide facilitates efficient collagen depletion for boosting pancreatic cancer phototheranostics10.1002/adma.202306476 ↗
46. Nitric-oxide-enhanced positively charged semiconductor conjugated polymer composite nanomaterials for antibiofilm in vivo10.1002/adfm.202415134 ↗
47. Light-activated nitric-oxide overproduction theranostic nanoplatform based on long-circulating biomimetic nanoerythrocyte for enhanced cancer gas therapy10.1007/s11426-021-1045-9 ↗
48. Acceptor-donor-acceptor-type molecules with large electrostatic potential difference for effective NIR photothermal therapy10.1039/D4TB00187G ↗
49. Supramolecular prodrug-like nanotheranostics with dynamic and activatable nature for synergistic photothermal immunotherapy of metastatic cancer10.1016/j.jconrel.2024.01.052 ↗
50. Near-infrared-II fluorophore with inverted dependence of fluorescence quantum yield on polarity as potent phototheranostics for fluorescence-image-guided phototherapy of tumors10.1002/adma.202209647 ↗
51. As aggregation-induced emission meets with noncovalent conformational locks: subtly regulating NIR-II molecules for multimodal imaging-navigated synergistic therapies
52. NIR-II absorbing conjugated polymer nanotheranostics for thermal initiated NO enhanced photothermal therapy10.3390/bios13060642 ↗
53. Zwitterionic AIEgens: rational molecular design for NIR-II fluorescence imaging-guided synergistic phototherapy10.1002/adfm.202007026 ↗
54. Selenium-integrated conjugated oligomer nanoparticles with high photothermal conversion efficiency for NIR-II imaging-guided cancer phototheranostics in vivo10.1186/s12951-023-02080-1 ↗
55. Phototheranostic agents based on nonionic heptamethine cyanine for realizing synergistic cancer phototherapy10.1002/adhm.202202817 ↗
56. Atomic-iodine-substituted polydiacetylene nanospheres with boosted intersystem crossing and nonradiative transition through complete radiative transition blockade for ultraeffective phototherapy10.1002/agt2.576 ↗